Liu Jinfeng has hosted 2 projects of National Natural Science Foundation of China, participated in 6 projects of National Natural Science Foundation of China and participated in Major Special Research Project for Infectious Diseases during the 11th, 12th and 13th Five-Year Plan of Ministry of Science and Technology. She published nearly 20 articles in SCI-indexed journals as the first/corresponding author. She participated in the formulation of the first evidence-based Guidelines for Prevention and Treatment of Mother-to-Child Transmission of Hepatitis B Virus in China (2019 Edition).
Liu Jinfeng hosted or participated in the following national research projects in recent 5 years:
1. Surface Project of National Natural Science Foundation of China (Regulation of IL-6 on NTCP-mediated HBV placental cell infection and direct infection between cells, January);
2. Youth Project of National Natural Science Foundation of China (Post-transcriptional regulation of HIV-1 virus gene by hRIP);
3. Surface Project of National Natural Science Foundation of China (Study of relationship between cells and mitochondrial autophagy and trophoblast injury and intrauterine transmission of HBV infection);
4. Surface Project of National Natural Science Foundation of China (Study of relationship between cells and mitochondrial autophagy and trophoblast injury and intrauterine transmission of HBV infection);
5. Surface Project of National Natural Science Foundation of China (Mechanism of mitochondrial autophagy mediated by phosphorylated Atg13 in activation of hepatic stellate cells);
6. Major Science and Technology Project in the 13th Five-Year Plan (Study of new antiviral/immunotherapy regimes for improving HBsAg negative rate in HBeAg-positive chronic hepatitis B patients)
7. Major Science and Technology Project in the 12th Five-Year Plan (Study of early warning mechanism of viral hepatitis outcomes);
8. Major Science and Technology Project in the 11th Five-Year Plan (Study of early warning mechanism of viral hepatitis outcomes);
9. National Natural Science Foundation of China (Study of NK cell functional defects in family cluster HBV infection with adverse outcomes);
10. National Natural Science Foundation of China (Study of host factors in family cluster HBV infection with adverse outcomes);
11. National Natural Science Foundation of China (In vitro and in vivo study of carcinogenesis of HBV pre-X gene)